Update on the optimal use of bortezomib in the treatment of multiple myeloma
Meera Mohan, Aasiya Matin, Faith E Davies Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA Abstract: The proteasome inhibitor (PI) “bortezomib” has now been in routine clinical practice for over a decade. It is now c...
| Главные авторы: | , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
Dove Medical Press
2017-03-01
|
| Серии: | Cancer Management and Research |
| Предметы: | |
| Online-ссылка: | https://www.dovepress.com/update-on-the-optimal-use-of-bortezomib-in-the-treatment-of-multiple-m-peer-reviewed-article-CMAR |